| Value | ₹0.00 Cr |
|---|
BSE filing, NSE: IONEXCHANG. Summary written from the filing by ALFA Finder's alert engine.
Ion Exchange (India) Ltd: key numbers
- Share price
- ₹342.35
- Market cap
- ₹5,021 Cr
- Revenue (annual)
- ₹2,915 Cr
- Net profit (annual)
- ₹142.7 Cr
- P/E (TTM)
- 51.2×Sector 21.4×
- Promoter holding
- 25.08%-0.35% QoQ
- FII holding
- 4.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ion Exchange (India) Ltd
All →Ion Exchange (India) Board Meeting Date
Ion Exchange India gave prior intimation of a November 3, 2026 board meeting to consider unaudited Q2 and H1 results. The filing is a future meeting notice with no results figures attached.
Ion Exchange (India) Other Announcement
Ion Exchange (India) Limited has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulation 31(1)(b).
Ion Exchange (India) Promoter Selling: ₹15.46 Cr
Promoter group member Dinesh Sharma sold 3,50,450 equity shares of Ion Exchange India Ltd via market sale, reducing stake by 0.24%.
- Value
- ₹15.46 Cr
- Promoter stake change
- -0.24%
Ion Exchange (India) Annual General Meeting
Ion Exchange (India) Limited held its 62nd Annual General Meeting on September 11, 2026, passing resolutions on financials, dividend, director re-appointment, and auditor remuneration.
Ion Exchange (India) Promoter Buying (Off-Market)
Promoter group member Dinesh Sharma transferred 2,30,000 equity shares to Dhruv Dinesh Trigunayat via an off-market gift transaction.
Ion Exchange (India) Annual Report
Ion Exchange (India) Limited has filed its 62nd Annual Report for the financial year 2025-26 with the stock exchanges.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date